Neurogene Inc. (NGNE)
NASDAQ: NGNE
· Real-Time Price · USD
22.96
1.29 (5.95%)
At close: Jun 05, 2025, 3:59 PM
5.95% (1D)
| Bid | 21.13 |
| Market Cap | 327.46M |
| Revenue (ttm) | 925K |
| Net Income (ttm) | -80.87M |
| EPS (ttm) | -4.36 |
| PE Ratio (ttm) | -5.27 |
| Forward PE | -4.31 |
| Analyst | Buy |
| Ask | 23.2 |
| Volume | 265,642 |
| Avg. Volume (20D) | 278,495 |
| Open | 17.82 |
| Previous Close | 21.67 |
| Day's Range | 17.82 - 23.17 |
| 52-Week Range | 6.88 - 74.49 |
| Beta | 1.58 |
About NGNE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NGNE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NGNE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-7.12%
Neurogene shares are trading lower after Baird dow...
Unlock content with
Pro Subscription
6 months ago
-42.58%
Neurgogene shares are trading lower after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett syndrome patient.
